Summary
This Form 8-K filing by Alnylam Pharmaceuticals, Inc. (ALNY) reports a change in its Board of Directors. Specifically, on February 11, 2008, Dr. Edward M. Scolnick was elected as a Class III director, with his term set to expire at the 2010 annual stockholders' meeting. In connection with his appointment, Dr. Scolnick was granted a stock option to purchase 45,000 shares of common stock, which will vest over a three-year period. His compensation will follow the company's established policy for non-employee directors, as previously detailed in their 2007 Proxy Statement. This filing is primarily administrative, informing investors of a board composition change and associated executive compensation.
Key Highlights
- 1Dr. Edward M. Scolnick elected to the Board of Directors on February 11, 2008.
- 2Dr. Scolnick's term as a Class III director extends to the 2010 annual stockholders' meeting.
- 3A stock option grant for 45,000 shares was issued to Dr. Scolnick upon his election.
- 4The stock option vests annually over a three-year period.
- 5Dr. Scolnick's compensation will adhere to the company's standard policy for non-employee directors.
- 6Compensation policy details are available in the 2007 Annual Meeting Proxy Statement.
Frequently Asked Questions
While the 8-K does not provide extensive background on Dr. Scolnick, his election suggests the company sought to bring his expertise to the board. Investors may wish to consult Alnylam's proxy statements or other company communications for more details on his qualifications and the strategic reasons for his appointment.
The stock option grant aligns Dr. Scolnick's interests with those of the company's shareholders. The three-year vesting schedule indicates a commitment to long-term value creation and incentivizes him to contribute to the company's performance over that period.
The filing states that details regarding the company's compensation policy for non-employee directors are described in Alnylam Pharmaceuticals' Proxy Statement for the 2007 Annual Meeting of Stockholders, filed on April 30, 2007.